HAVN Life Sciences Inc. (HAVN.CN) Research

HAVN Life Sciences Inc. is a biotechnology firm dedicated to the research and creation of psychotropic compounds sourced from flora and fungi. The company's expertise includes devising standardized and quality-assured extraction techniques for psychoactive substances, particularly from Psilocybe mushrooms, to isolate key compounds such as psilocybin, psilocin, and baeocystin. Furthermore, it develops natural health remedies using non-regulated ingredients. This Canadian company, founded in 2020, is headquartered in Richmond.

Market snapshot

Symbol
HAVN.CN
Price
$0.03
Day change
0.00%
Market cap
$1.2M
P/E ratio
-0.01x
52-week range
0.03-0.03
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Braxia Scientific Corp. (BRAX.CN)
  • BC Craft Supply Co. Ltd. (CRFT.CN)
  • Nirvana Life Sciences Inc. (NIRV.CN)
  • Enlighta Inc. (NLTA.V)
  • PsyBio Therapeutics Corp. (PSYB.V)
  • Pure Extracts Technologies Corp. (PULL.CN)
  • RepliCel Life Sciences Inc. (RP.V)
  • SLANG Worldwide Inc. (SLNG.CN)

Open HAVN Life Sciences Inc. (HAVN.CN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.